Data from more than 100 company-sponsored, investigator-sponsored, and collaborative research abstracts, including 13 oral presentations and four poster spotlights, will be shared across the com ...
From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...
Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...
(MENAFN- The Conversation) From today, February 3 , pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation Program . This vaccine is designed to ...
From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation Program. This vaccine is designed to protect young infants from severe ...
Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.
Pregnant women across the Northern Territory now have free access to protection against a virus that is the leading cause of hospitalisation for babies. The federal government is investing $174.5m ...
Two RSV vaccines were approved for use in Australia last year by the Therapeutic Goods Administration. The Australian Government is funding Pfizer’s Abrysvo for pregnant women and, in an unusual ...
Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.